The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Bertolini Robert J since year 2005.
The trader's CIK number is 1270263.
At the time of the last reporting, Bertolini Robert J was the Officer of Bristol Myers Squibb Co .
(stock ticker symbol BMY).
See this page for all insider trading activities at Bristol Myers Squibb Co .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-07-31||BMY||Bristol Myers Squibb Co||Buy||11,000||44.72||491,920|
|2018-12-04||CRL||Charles River Laboratories International Inc||Option Ex||4,540||33.93||154,042|
|2018-12-04||CRL||Charles River Laboratories International Inc||Sale||3,440||133.82||460,344|
|2018-12-04||CRL||Charles River Laboratories International Inc||Sale||1,100||134.73||148,203|
|2018-01-02||CRL||Charles River Laboratories International Inc||Sale||3,609||110.27||397,957|
|2018-01-02||CRL||Charles River Laboratories International Inc||Option Ex||7,740||40.27||311,689|
|2018-01-02||CRL||Charles River Laboratories International Inc||Sale||4,131||109.59||452,712|
|2017-03-01||CRL||Charles River Laboratories International Inc||Option Ex||11,990||37.81||453,341|
|2017-03-01||CRL||Charles River Laboratories International Inc||Sale||5,255||87.50||459,833|
|2017-03-01||CRL||Charles River Laboratories International Inc||Sale||6,735||88.04||592,976|
|2011-04-04||GENZ||Genzyme Corp||Option Ex||2,375||.00||0|
|2010-06-16||GENZ||Genzyme Corp||Option Ex||2,375||.00||0|
|2009-04-01||SGP||Merck & Co., Inc.||Option Ex||40,000||.00||0|
|2008-04-25||SGP||Merck & Co., Inc.||Option Ex||45,000||.00||0|
|2006-12-01||SGP||Merck & Co., Inc.||Option Ex||45,000||.00||0|
|2006-11-17||SGP||Merck & Co., Inc.||Option Ex||65,000||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bertolini Robert J (Officer of Bristol Myers Squibb Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.